| (P693) |
Genetische Variabilität im bag3-Gen (BCL2-associated athanogene 3) bei Patienten mit dilatativer Kardiomyopathie |
|
V. Ruppert, C. Ondo-Ona, T. Meyer, A. Richter, S. Pankuweit und KNHI (Marburg, Göttingen) |
| (P694) |
The role of HMGB1 in autoimmune myocarditis |
|
M. Andrassy, H. C. Volz, A. Bangert, D. Laohachewin, S. Göser, F. Lasitschka, R. Öttl, V. Vukovic, K. Keilbach, A. Bierhaus, H. A. Katus, Z. Kaya (Heidelberg) |
| (P695) |
The immune protein NOD-2 modulates left ventricular performance in a gender-specific manner in experimental pressure overload-induced heart failure112 |
|
J. Rüdebusch, S. Heinrich, S. B. Felix, A. Riad (Greifswald) |
| (P696) |
Adiponectin promotes coxsackievirus B3 myocarditis by suppressing the acute antiviral immune response |
|
A. Jenke, P. M. Becher, S. Wilk, A. Weithäuser, K. Klingel, H.-P. Schultheiss, C. Scheibenbogen, C. Skurk (Berlin, Tübingen) |
| (P697) |
Regulatory T cells reduce myocardial inflammation and fibrosis and improve hemodynamic function in a mouse model of viral myocarditis |
|
K. Savvatis, K. Pappritz, P. M. Becher, D. Westermann, D. Lindner, H.-D. Volk, H.-P. Schultheiss, C. Tschöpe (Berlin) |
| (P698) |
Novel insights into the role of heme oxygenase-1 in viral myocarditis |
|
O. Ursu, M. Sauter, N. Ettischer, R. Kandolf, K. Klingel (Tübingen) |
| (P699) |
Treatment with a VLA-4 Antibody Ameliorates Inflammation and Fibrosis in Experimental Autoimmune Myocarditis |
|
U. Grabmaier, J. Grabmeier, G. Kania, U. Eriksson, N. Herbach, R. Wanke, W.-M. Franz, S. Brunner (München; Zürich, CH) |
| (P700) |
Impact of Human Parvovirus B19-Mutants on Myocarditis and Dilated Cardiomyopathy |
|
C.-T. Bock, F. Utta, E. C. Brunner, K. Klingel, R. Kandolf (Berlin, Tübingen) |
| (P701) |
Endothelial microparticles reflecting vascular damage in Parvo B19-positive myocarditis |
|
K. Bachelier, S. Biehl, A. Yilmaz, V. Schwarz, I. Kindermann, C. Ukena, K. Klingel, R. Kandolf, U. Sechtem, M. Böhm (Homburg/Saar, Stuttgart, Tübingen) |
| (P702) |
irculating neutrophils predict long term mortality in patients with recent onset dilated cardiomyopathy and display suppressed Toll-like receptor 4/IRF-3-pathway |
|
A. Riad, M. Hundt, S. Gamradt, L. R. Herda, M. Nauck, M. Dörr, S. B. Felix (Greifswald) |
| (P703) |
Indikation und Häufigkeit einer ICD-Therapie bei Patienten mit Verdacht auf Myokarditis |
|
C. Ukena, M. Kindermann, F. Mahfoud, D. Fischer, H.-R. Neuberger, M. Böhm, I. Kindermann (Homburg/Saar, Saarbrücken) |